JNJ

192.13

-0.43%↓

ABT

126.16

-2.02%↓

MDT

94.35

-2.11%↓

VEEV

290.48

+0.43%↑

A

147.3

+0.98%↑

JNJ

192.13

-0.43%↓

ABT

126.16

-2.02%↓

MDT

94.35

-2.11%↓

VEEV

290.48

+0.43%↑

A

147.3

+0.98%↑

JNJ

192.13

-0.43%↓

ABT

126.16

-2.02%↓

MDT

94.35

-2.11%↓

VEEV

290.48

+0.43%↑

A

147.3

+0.98%↑

JNJ

192.13

-0.43%↓

ABT

126.16

-2.02%↓

MDT

94.35

-2.11%↓

VEEV

290.48

+0.43%↑

A

147.3

+0.98%↑

JNJ

192.13

-0.43%↓

ABT

126.16

-2.02%↓

MDT

94.35

-2.11%↓

VEEV

290.48

+0.43%↑

A

147.3

+0.98%↑

Search

Organon & Co

Ouvert

SecteurSoins de santé

8.96 -1.32

Résumé

Variation du prix de l'action

24h

Actuel

Min

8.86

Max

9.02

Chiffres clés

By Trading Economics

Revenu

-174M

-87M

Ventes

81M

1.6B

P/E

Moyenne du Secteur

3.435

37.461

BPA

1

Rendement du dividende

9.27

Marge bénéficiaire

-5.443

Employés

10,000

EBITDA

124M

449M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+77.38% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

9.27%

2.33%

Prochains Résultats

30 oct. 2025

Date du Prochain Dividende

11 déc. 2025

Date du Prochain Détachement de Dividende

12 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-101M

2.4B

Ouverture précédente

10.28

Clôture précédente

8.96

Sentiment de l'Actualité

By Acuity

50%

50%

168 / 371 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Organon & Co Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 oct. 2025, 22:47 UTC

Acquisitions, Fusions, Rachats

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22 oct. 2025, 22:13 UTC

Acquisitions, Fusions, Rachats

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22 oct. 2025, 21:20 UTC

Résultats

Correction to IBM 3Q Sales Jump Article

22 oct. 2025, 20:57 UTC

Résultats

SAP Posts Higher 3Q Revenue, Operating Profit

22 oct. 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 oct. 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22 oct. 2025, 23:41 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 oct. 2025, 23:38 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 oct. 2025, 23:15 UTC

Résultats

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22 oct. 2025, 22:28 UTC

Market Talk

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22 oct. 2025, 22:02 UTC

Résultats

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22 oct. 2025, 21:59 UTC

Acquisitions, Fusions, Rachats

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22 oct. 2025, 21:58 UTC

Acquisitions, Fusions, Rachats

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22 oct. 2025, 21:57 UTC

Acquisitions, Fusions, Rachats

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22 oct. 2025, 21:56 UTC

Acquisitions, Fusions, Rachats

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22 oct. 2025, 21:47 UTC

Acquisitions, Fusions, Rachats

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22 oct. 2025, 21:47 UTC

Résultats

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 oct. 2025, 21:47 UTC

Acquisitions, Fusions, Rachats

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22 oct. 2025, 21:46 UTC

Acquisitions, Fusions, Rachats

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22 oct. 2025, 21:45 UTC

Acquisitions, Fusions, Rachats

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22 oct. 2025, 21:45 UTC

Acquisitions, Fusions, Rachats

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22 oct. 2025, 21:28 UTC

Market Talk
Résultats

Correction to Alcoa Tariff Market Talk

22 oct. 2025, 21:25 UTC

Résultats

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22 oct. 2025, 21:17 UTC

Résultats

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22 oct. 2025, 21:09 UTC

Market Talk
Résultats

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22 oct. 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

22 oct. 2025, 20:59 UTC

Résultats

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 oct. 2025, 20:51 UTC

Résultats

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22 oct. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 oct. 2025, 20:44 UTC

Résultats

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Comparaison

Variation de prix

Organon & Co prévision

Objectif de Prix

By TipRanks

77.38% hausse

Prévisions sur 12 Mois

Moyen 16 USD  77.38%

Haut 18 USD

Bas 14 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

1

Achat

0

Maintien

1

Vente

Score Technique

By Trading Central

8.53 / 9.18Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

168 / 371Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Organon & Co

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.
help-icon Live chat